Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,055.00GBp
2 Dec 2016
Change (% chg)

-25.00p (-0.61%)
Prev Close
4,080.00p
Open
4,048.00p
Day's High
4,078.00p
Day's Low
3,999.00p
Volume
3,200,423
Avg. Vol
2,908,468
52-wk High
5,505.00p
52-wk Low
3,680.00p

Pott, Jeffrey 

Mr. Jeffrey Pott is General Counsel of AstraZeneca Plc., Since January 2009 and has overall responsibility for all aspects of AstraZeneca’s Legal and IP function. He joined AstraZeneca in 1995 and has worked in various litigation roles, where he has had responsibility for IP, anti-trust and product liability litigation. Before joining AstraZeneca, he spent five years at the US legal firm Drinker Biddle and Reath LLP, where he specialised in pharmaceutical product liability litigation and anti-trust advice and litigation. He received his bachelor’s degree in political science from Wheaton College and his Juris Doctor Degree from Villanova University School of Law.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

609,000

Pascal Soriot

8,397,000

Marc Dunoyer

5,955,000

Fiona Cicconi

--

Sean Bohen

--

Pam Cheng

--
As Of  30 Dec 2015